MAP2K1 and Langerhans cell histiocytosis: Rencently, another retrospective cohort study from the Netherlands and Canada on pediatric LCH reported 54 patients with MAP2K1 mutations, 39 with BRAF exon 12 mutations, and 13 with rare BRAF alterations.